Real-time enrollment status for this advanced solid tumor clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:03 AM UTC
| NCT Number | NCT05932862 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 429 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Exelixis |
| Last Updated on CT.gov | September 5, 2025 (Sep 5, 2025) |
As of August 28, 2026: Clinical trial NCT05932862 is currently recruiting participants. This phase1 study for advanced solid tumor is actively seeking new participants at 16 locations across the United States. The study is sponsored by Exelixis. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05932862 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05932862 was last updated Sep 5, 2025 (September 5, 2025). HelloStudys verifies this status automatically.